Review of Metaplastic Carcinoma of the Breast: Imaging Findings and Pathologic Features

Address for correspondence: Dr. Rebecca Leddy, Department of Radiology and Radiological Science, Medical University of South Carolina, 96 Jonathan Lucas St. MSC 323, Charleston, SC 29425, USA. E-mail: leddyr@musc.edu

Received: 2012-03-16, Accepted: 2012-03-25, Published: 2012-04-28

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Disclaimer:
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.

Source of Support: Nil

Conflict of Interest: None declared.

Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2012/2/1/21/95435

Abstract

Metaplastic carcinoma (MPC), an uncommon but often aggressive breast cancer, can be challenging to differentiate from other types of breast cancer and even benign lesions based on the imaging appearance. It has a variable pathology classification system. These types of tumors are generally rapidly growing palpable masses. MPCs on imaging can present with imaging features similar to invasive ductal carcinoma and probably even benign lesions. The purpose of this article is to review MPC of the breast including the pathology subtypes, imaging features, and imaging pathology correlations. By understanding the clinical picture, pathology, and overlap in imaging characteristics of MPC with invasive ductal carcinoma and probably benign lesions can assist in diagnosing these difficult malignancies.

Keywords

Metaplastic carcinoma

spindle cell

invasive ductal carcinoma

Show Related Articles from PubMed

INTRODUCTION

Metaplastic carcinoma (MPC) of the breast is an uncommon form of breast cancer comprising less than 5% of breast cancer patients.[1] It consists of a heterogenous group of malignant neoplasms containing both glandular and non-glandular components with mixed epithelial and mesenchymal differentiation.[2] The classification of MPCs according to the various systems can be confusing. The World Health Organization classifies MPC into (1) epithelial type and (2) mixed type with further differentiation into subtypes.[3] The more popular Wargotz and Norris classification differentiates MPCs into 5 subtypes: spindle cell, squamous cell, carcinosarcoma, matrix-producing, and MPC with osteoclastic giant cells.[2 4–6] The differential diagnosis between invasive ductal carcinoma, MPC, and breast sarcoma is important for management and prognosis.

CLINICOPATHOLOGICAL FEATURES

MPCs often present as a palpable breast mass in women more than 50 years of age.[5 7] The lesions are characterized by larger tumor size and rapid growth.[4 8] MPCs are often not associated with estrogen and progesterone receptors, or HER2 expression.[4 9 10] The axillary lymph node involvement at the time of presentation is variable with rates ranging from 8% to 40%.[4 5 8] There is a high hematogenous metastatic potential to lung and bone rather than lymphatic spread.[1 4 6] There is a documented increased risk of tumor recurrence and worse prognosis with MPC compared with invasive ductal or invasive lobular carcinoma.[3 4 7] Several predictors affecting a poorer outcome are presence of skin invasion, younger age (less than 39 years of age) at presentation, and appearance of squamous cell carcinoma in the lymph nodes.[3] The subtype of MPC has no effect on outcome.[3]

PATHOLOGIC SUBTYPES AND FEATURES

Most cases of MPC are sporadic. The spindle cell subtype is the most common of the 5 subtypes classified by Wargotz and Norris. The spindle cell subtype demonstrates cells forming poorly cohesive sheets or predominant spindle cell morphology [Figure 1].[2 4 9] The spindle cell component often resembles a low-grade sarcoma or reactive process such as granulation tissue which can be challenging to differentiate.[4] The squamous cell carcinoma subtype demonstrates infiltrating squamous carcinoma with polygonal cells, eosinophilic cytoplasm, and possible keratin pearl formation [Figure 2].[4 9] The carcinosarcoma contains both malignant epithelium and malignant stroma.[2 4] The matrix-producing subtype contains overt carcinoma with transition to cartilaginous and/or osseous stromal matrix without a spindle component.[2 10] The MPC with osteoclastic giant cells subtype shows intraductal or infiltrating carcinoma contiguous or mixed with spindle cell or sarcomatous stroma plus osteoclastic cells [Figure 3].[4]

IMAGING FEATURES OF METAPLASTIC CARCINOMA

The mammographic appearance of MPC has been described as a high-density mass with either circumscribed, obscured, irregular, spiculated, or circumscribed with partially spiculated margins [Figure 4].[1 5–7 11 12] Yang et al., reported more benign appearance on mammogram including round or oval shape and circumscribed margins of a mass compared with invasive ductal carcinoma.[6] The lesions are often non-calcified.[5] If calcifications are present, the pattern is amorphous, coarse, punctate, or pleomorphic [Figure 5].[7 11] Park et al., described a high rate of architectural distortion associated with MPC.[11]

The sonographic appearance of MPCs have been previously described as a heterogenous or hypoechoic solid mass or mixed cystic and solid mass [Figures 6–8].[5–7 11] The mass is oval, round, lobular, or irregular shaped with circumscribed, microlobulated, irregular, or indistinct margins [Figures 6–8].[5–7 11] Yang et al., reported more benign features of oval, round, or lobular solid hypoechoic mass with circumscribed or indistinct margins in contrast to invasive ductal carcinoma [Figure 7].[6] MPCs often demonstrate posterior acoustic enhancement compared with posterior shadowing most often seen with invasive ductal carcinoma [Figures 6 and 8].[6 7]

The MRI features described for MPC are an irregular mass with spiculated margins, often intermediate to increased T2 signal intensity and isointense or hypointense on T1-weighted imaging [Figures 9 and 10].[7 12] Velasco et al., reported an increase in T2 hyperintensity in cancers of 11 of 12 patients (91%) with MPC.[12] Although T2 hyperintensity is often associated with benign lesions, it can be secondary to necrosis, or mucoid production in cancer. The T2 hyperintensity with MPC is reported secondary to necrosis with differential considerations including invasive ductal carcinoma with abundant necrosis and mucinous carcinoma.[12] The documented enhancement characteristics of these lesions include ring-like, homogenous, heterogeneous, or containing non-enhancing internal components [Figures 9 and 10].[7 12] The kinetic pattern may be variable but more often reported as early enhancement with delayed washout or plateau pattern.[7 12]

IMAGING PATHOLOGY CORRELATION

Spindle cell subtype of MPC is more likely to have circumscribed margins.[5] A circumscribed margin with a spiculated portion is often seen in MPC with a mixture of metaplastic and invasive carcinoma not otherwise specified [Figure 4].[5] Solid and cystic components correlated on pathology with MPCs containing necrosis, hemorrhage, cystic degeneration, and matrix formation [Figures 8, 10 and 11].[5 11] The lesions with more cystic components were associated with squamous components [Figure 11].[11]

CONCLUSION

MPC should be differentiated from invasive ductal or invasive lobular carcinoma and primary breast sarcoma in order to determine appropriate treatment options, management considerations, and patient outcome. The pathology classification of MPCs is often variable. The mammographic, sonographic, and MRI imaging characteristics of MPCs can be similar to invasive ductal carcinoma as well as probably benign features. The imaging appearance reported similar to invasive ductal carcinoma includes an irregular or circumscribed palpable mass with spiculated portion on mammography and solid irregular vs. mixed cystic and solid mass on ultrasound. Prior papers have also reported presentations with imaging features more suggestive of benign masses including circumscribed round or oval masses on mammogram, oval, round, or lobular circumscribed hypoechoic solid mass with posterior acoustic enhancement on ultrasound, and T2 hyperintensity on MRI. By understanding the clinical picture, pathology, and overlap in imaging characteristics of MPC with invasive ductal carcinoma and probably benign lesions can assist in diagnosing these difficult malignancies.

REFERENCES

Oberman HA, . Metaplastic carcinoma of the breast. Am J Surg Pathol. 1987;11:918-29.
[Google Scholar]
Brenner JR, Turner RR, Schiller V, Arndt R, Giuliano A, . Metaplastic carcinoma of the breast: Report of three cases. Am Cancer Soc. 1998;82:1082-87.
[Google Scholar]
Okada N, Hasebe T, Iwasaki M, Tamura N, Akashi-Tanaka S, Hojo T, . Metaplastic Carcinoma of the breast. HumPathol. 2010;41:960-70.
[Google Scholar]
Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, . Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: The experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2007;101:349-53.
[Google Scholar]
Gunhan-Bilgen I, Memis A, Ustun EE, Zekioglu O, Ozdemir N, . Metaplastic carcinoma of the breast: Clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol. 2002;178:1421-5.
[Google Scholar]
Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, . Imaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol. 2007;189:1288-92.
[Google Scholar]
Shin HJ, Kim HH, Kim SM, Kim DB, Kim MJ, Gong G, . Imaging features of metaplastic carcinoma with chondroid differentiation of the breast. AJR Am J Roentgenol. 2007;188:691-6.
[Google Scholar]
Park HS, Park S, Kim JH, Lee JH, Choi SY, Park BW, . Clincopathologic features and outcomes of metaplastic breast carcinoma: Comparison with invasive ductal carcinoma of the breast. Yonsei Med J. 2010;51:864-9.
[Google Scholar]
Tse GM, Tan PH, Lui PC, Chaiwun B, Law BK, . Metaplastic carcinoma of the breast: A clinicopathological review. J Clin Pathol. 2006;59:1079-83.
[Google Scholar]
Ayar S, Dysee L, Carter E, . Matrix-producing carcinoma: A rare variant of metaplastic breast carcinoma with heterologous elements. Breast J. 2010;16:420-3.
[Google Scholar]
Park JM, Han BK, Moon WK, Choe YH, Ahn SH, Gong G, . Metaplastic carcinoma of the breast: Mammographic and sonographic findings. J Clin Ultrasound. 2000;28:179-86.
[Google Scholar]
Velasco M, Santamaría G, Ganau S, Farrús B, Zanón G, Romagosa C, . MRI of metaplastic carcinoma of the breast. AJR Am J Roentgenol. 2005;184:1274-8.
[Google Scholar]